CASC3 and Miyoshi myopathy: Our study shows that AMD-L as deliveryvehicles mitigate adverseeffects while enhancing therapeutic efficacy within bone tissues.The encapsulation of BTZ in liposomes containing a bone targetingmoiety in the form of AMD represents a promising therapeutic strategyfor MM, and possibly other bone-related diseases.